Tokyo, Japan

Kazuyuki Tabata


 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuyuki Tabata: Innovator in Antibody Production

Introduction

Kazuyuki Tabata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant antibodies. With a total of 3 patents to his name, Tabata's work has the potential to revolutionize antibody production methods.

Latest Patents

Tabata's latest patents focus on innovative methods for producing antibodies efficiently and at low cost. One of his notable inventions is a composition comprising an antibody, which provides a method of producing a recombinant antibody. This method involves allowing a cell to produce the antibody or a fragment thereof, wherein the cell contains a larger number of copies of an exogenous DNA encoding the light chain than the heavy chain. Additionally, he has developed a recombinant vector that comprises one copy of a DNA encoding the heavy chain and two or more copies of a DNA encoding the light chain.

Career Highlights

Kazuyuki Tabata is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on advancing antibody production techniques, contributing to the company's innovative research and development efforts.

Collaborations

Throughout his career, Tabata has collaborated with notable colleagues, including Yoshiki Yamada and Tatsuya Kiyasu. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kazuyuki Tabata's contributions to antibody production highlight his role as a key innovator in biotechnology. His patents and work at Chugai Seiyaku Kabushiki Kaisha demonstrate his commitment to advancing scientific research and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…